Consulting BusinessHealthcare BusinessAI, AX, DX BusinessInvestment & Advisory BusinessNail BusinessNail Salon MagiqueFASTNAILFast Nail PlusKonvano Nail Business AcademyKonvano ConsultingSinks HealthcareM&A TechnoMerge ConsultingDataStrategyToranomon Capital
Implemented third-party allotment of capital increase (change of controlling shareholder).
Established consolidated subsidiary Convano Consulting Inc.
Established consolidated subsidiary Sinks Healthcare Inc.
Established consolidated subsidiary M&A Technomaj Consulting Inc.
Renamed M&A Technomaj Consulting Inc. to Toranomon Capital Inc.
Achieved sales revenue over 3 billion yen in FY March 2025.
Issued the 4th series of new stock rights (with exercise price adjustment clause) to Dimensional Inc. through third-party allotment and concluded a subscription agreement for the new stock rights.
Established consolidated subsidiary DataStrategy Inc.
Established a new shareholder benefit program (providing Bitcoin and FASTNAIL discount vouchers).
Issued paid stock options (new stock rights).
Achieved sales over 9 billion yen in Q3 FY March 2026.
Expanded the shareholder benefit program to include free FASTNAIL nail service vouchers.
§07
News
29 ARTICLES
Announcement of the 2027 March Fiscal Year Interim Results
Our company announced the consolidated financial results for the second quarter of the 2027 March fiscal year (April 1, 2026 – September 30, 2026). Revenue was 15.3 billion yen, a year-over-year increase of 299.1%, and operating profit was 4.1 billion yen, a year-over-year increase of 127.4%. The performance contribution from our consolidated subsidiary in the consulting business and the expansion of high-value pharmaceutical products in the healthcare business drove the results, achieving significant revenue and profit growth.
Resolution to Fully Subscribe the 34th Series of Stock Options Issued by Consolidated Subsidiary Accelmark
At the board of directors meeting held on November 13, 2026, the company resolved to fully subscribe to the 116,500 shares of the 34th series of stock options to be issued by its consolidated subsidiary Accelmark Co., Ltd. through a third‑party allocation.
Decision to cancel 3,728,960 shares of treasury stock
Convano Co., Ltd. decided at its board meeting held on November 13, 2026 to cancel all 3,728,960 shares of treasury stock it acquired from Dimensional Co., Ltd. on October 21, 2026.
Medical AI 'AXON' to Be Presented at the 18th Japanese Society of Health and Medical Sciences Annual Meeting
Shohei Nambu of Convano Inc.'s AI Development Office will speak at a sponsored seminar during the 18th Japanese Society of Health and Medical Sciences Annual Meeting on October 4, 2026.
Overview of Medical AI Concept ‘AXON’ Published
As part of its growth strategy, Convano Inc. published an overview of AXON, its concept for AI agents specialized for medical institutions. The company also held a web briefing and posted an archived video of the session.
Medical AI AXON exhibited and presented at Japan College of Cardiology meeting
Convano Inc. exhibited its medical AI product AXON at a special booth at the 74th Annual Scientific Meeting of the Japanese College of Cardiology, held on Saturday, September 12, 2026. A physician who oversees AXON also gave a mini-seminar, introducing the latest AI technology to attendees.
Medical AI “AXON” concept video released; online briefing scheduled
The company released a concept video for AXON, an AI agent system for medical institutions. It will also hold an online briefing on Friday, September 18, 2026, from 4:00 to 5:00 p.m., answering questions submitted in advance.
Medical AI “AXON” to exhibit at 74th Annual Meeting of the Japanese College of Cardiology
The company will exhibit a special booth for its medical AI system AXON at the 74th Annual Meeting of the Japanese College of Cardiology on Saturday, September 12, 2026. A physician advising AXON is also scheduled to speak at a mini-seminar.
Convano Approves Paid Stock Options to Support Growth of AI Business Including AXON
Convano Inc. resolved to issue paid stock options (sixth series of stock acquisition rights) to promote growth in its AI business, including AXON, an AI service for medical institutions.
Two Physicians Developing Medical AI AXON Appointed Executive Officers for AI Business
Convano Inc. appointed Shohei Nambu and Hiromitsu Nakamura, who have been involved in planning and developing AXON, an AI system for medical institutions, as executive officers responsible for the AI business effective September 1, 2026.
§08
Public records
GOV
National Tax Agency basic information8011001095822
Source: National Tax Agency Corporate Number Publication Site, basic three items
Trade name
株式会社コンヴァノ
Trade name (kana)
コンヴァノ
Name in English
Corporation type
301
Address
〒150-0031 東京都渋谷区桜丘町22番14号N.E.S.ビルS棟B3F
Postal code
1500031
Prefecture code
13
City code
113
Address outside Japan
Prefecture in English
City in English
Address outside Japan in English
Corporate number assignment date
2015-10-05
Update date
2020-09-10
Change date
2015-10-05
Registry closure date
Reason for registry closure
Successor corporate number
Details of the change
Latest record
1
Excluded from search
0
Processing type
01
Correction type
1
Trade name image ID
Address image ID
Sequence number
2386222
METI gBizINFO8011001095822
Source: gBizINFO (Ministry of Economy, Trade and Industry)